TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
JNJ

Johnson & Johnson

Healthcare · Drug Manufacturers - General

269.20$ +0.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

Johnson & Johnson (JNJ) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 24,530 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow JNJ
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
3,891 4,343 4,886 5,677 6,563 8,864 8,176 10,595 11,131 11,877 14,248 15,249 14,972 16,571 16,385 14,298 15,396 17,414 18,471 19,279 18,767 21,056 22,201 23,416 23,536 23,410 21,194 22,791 24,266 24,530
1,009 1,067 1,246 1,444 1,515 1,605 1,662 1,869 2,124 2,093 2,177 2,777 2,832 2,774 2,939 3,158 3,666 4,104 3,895 3,746 3,754 5,642 6,929 7,009 7,231 7,390 6,970 7,486 7,339 7,503
559 698 627 628 614 621 662 728 792 874 878 962 978 977 1,005 1,135 1,138 1,162 1,176 1,354
250 982 -183 3,185 312 -768 -1,337 246 2,873 -28 -2,577 -1,099 -620 294
-2.0 94 656 62 328 1,493 -192 1,325 975 -912 982 1,453 -1,725 1,281 -870 1,651 -1,969 -941 -1,066 1,339 -1,773 11,241 3.0 3,865 2,690 -4,238 -4,011 2,507 1,837 -12,718
1,373 1,391 4,941 1,999 1,646 1,731 2,099 2,262 2,175 2,632 2,738 3,310 3,066 2,365 2,384 2,893 2,934 3,595 3,714 3,463 3,226 3,279 3,670 3,498 3,347 3,652 4,009 4,543 4,424 4,832
-1,692 -1,614 -5,639 -2,942 -2,368 -4,093 -2,197 -4,526 -2,347 -279 -20,291 -6,139 -4,187 -7,598 -7,854 -4,612 -4,510 -5,103 -12,305 -7,735 -4,761 -14,868 -3,167 -6,194 -20,825 -8,683 -12,371 878 -18,599 -23,588
974 1,137 1,305 1,479 1,724 2,047 2,381 2,746 3,251 3,793 4,267 4,670 5,024 5,327 5,804 6,156 6,614 7,286 7,768 8,173 8,621 8,943 9,494 9,917 10,481 11,032 11,682 11,770 11,823 12,381
-412 -628 -930 -840 -973 -2,570 -6,538 -1,183 -1,384 -1,717 -6,722 -5,607 -6,651 -2,130 -2,797 -2,525 -12,919 -3,538 -7,124 -5,290 -8,979 -6,358 -5,868 -6,746 -3,221 -3,456 -6,035 -5,054 -2,432 -5,953
2,483 2,395 2,983 -3,666 2,028 850 1,379 7,875 6,754 -3,949 -2,881 7,095 -990 7,452 -2,734 10,051 9,637
-1,368 -1,919 -98 -2,294 -3,100 -5,251 -6,953 -3,863 -5,148 -4,521 -6,109 -5,698 -7,464 -4,092 -4,980 -4,452 -20,562 -6,091 -12,260 -10,846 -8,551 -7,673 -18,510 -18,015 -6,120 -14,047 -8,871 -15,825 -3,132 -5,539
810 742 -826 369 1,048 -520 -864 2,483 3,826 6,852 -11,972 3,687 2,998 5,042 3,545 5,187 -9,631 6,016 -6,404 -791 5,240 -1,148 283 -802 -3,320 502 -360 7,732 2,246 -4,396
2,518 2,952 -55 3,678 4,917 7,133 6,077 8,333 8,956 9,245 11,510 11,939 11,906 14,206 14,001 11,405 12,462 13,819 14,757 15,816 15,541 17,777 18,531 19,918 20,189 19,758 17,185 18,248 19,842 19,698

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?